Other plasma expanders vs albumin: All‐cause mortality
It is very uncertain whether other plasma expanders changes all‐cause mortality compared with albumin (very low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Other plasma expanders vs albumin All‐cause mortality · cirrhotic participants with large ascites treated by paracentesis It is very uncertain whether other plasma expanders changes all‐cause mortality compared with albumin (very low certainty). Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis (2019) · Cochrane Headline outcomes only | RR 1.03 [0.82, 1.3] | 14 studies · 1014 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis 2019 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.